Semaglutide is a long-term drug that requires lifetime use to maintain weight loss. Weight rebound in Semaglutide trials In the semaglutide trial, after 68 weeks of subcutaneous injection of Semaglutide 2.4mg or placebo combined with a lifestyle intervention, the Semaglutide group lost an average of 17.3% of body weight and the placebo group lost an average of 2% of body …

When we see a person who is severely overweight, we used to think that this person doesn’t know how to control their diet, has not developed good eating habits, or is too lazy to exercise. We just think that obesity cause by lifestyle habits, if overweight people realize the harm to their health, diet and actively participate in exercise, back …